With a robust background in venture capital, the fund manager has successfully completed over 50 investments across the technology and healthcare sectors. Engaging primarily in early to growth-stage opportunities, they emphasize a data-driven approach to identify high-potential startups. Their strategic focus has led to notable exits in the software and biotech domains, demonstrating an ability to navigate complex markets. Active in both North American and European landscapes, they prioritize partnerships that foster innovation and long-term value creation.